CV vs TPR · rev $3.5M vs P/E 46, rev $8.00B
CapsoVision, Inc. Common Stock (CV) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
CV currently screens at market cap $359.2M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the CV and TPR stock pages for the full models.
Not investment advice.